Skip to main content

Nurix Therapeutics, Inc.

NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001549595

In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.

Q2 2025 vs. Q1 2025

How the institutions holding Nurix Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of NRIX: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders170164−6
Shares84.6M88.3M+3.72M (+4.4%)
Value$1.01B$1.01B+$824.6K (+0.1%)

New holders (24)

Institutions that held Nurix Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to NRIX in Q2 2025
InstitutionSharesValue% of portfolio
Handelsbanken Fonder AB280,000$3.19M0.01%
Polar Asset Management Partners Inc.154,400$1.76M0.04%
Bollard Group LLC122,782$1.40M0.03%
Algert Global LLC114,499$1.30M0.03%
Baird Financial Group, Inc.110,000$1.25M0.00%
Brevan Howard Capital Management LP62,871$716.1K0.01%
Trexquant Investment LP51,533$587.0K0.01%
Verition Fund Management LLC41,922$477.5K0.00%
Mach-1 Financial Group, Inc.32,087$365.5K0.11%
Man Group plc28,303$322.4K0.00%
Fox Run Management, L.L.C.18,902$215.3K0.04%
Creative Planning16,409$186.9K0.00%
Velan Capital Investment Management LP10,000$113.9K0.11%
Point72 (DIFC) Ltd2,916$33.2K0.00%
Raymond James Financial Inc1,618$18.4K0.00%
Point72 Hong Kong Ltd992$11.3K0.00%
Accent Capital Management, LLC250$2.85K0.00%
EverSource Wealth Advisors, LLC129$1.47K0.00%
Parkside Financial Bank & Trust100$1.14K0.00%
IFP Advisors, Inc0$3750.00%
CIBC Private Wealth Group, LLC27$3080.00%
SBI Securities Co., Ltd.18$2050.00%
Farther Finance Advisors, LLC9$1030.00%
Twin Peaks Wealth Advisors, LLC1$100.00%

Sold out (30)

Institutions that held Nurix Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.